Correlation Between Orexo AB and Moberg Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Orexo AB and Moberg Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Orexo AB and Moberg Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Orexo AB and Moberg Pharma AB, you can compare the effects of market volatilities on Orexo AB and Moberg Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Orexo AB with a short position of Moberg Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Orexo AB and Moberg Pharma.

Diversification Opportunities for Orexo AB and Moberg Pharma

-0.39
  Correlation Coefficient

Very good diversification

The 3 months correlation between Orexo and Moberg is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Orexo AB and Moberg Pharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Moberg Pharma AB and Orexo AB is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Orexo AB are associated (or correlated) with Moberg Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Moberg Pharma AB has no effect on the direction of Orexo AB i.e., Orexo AB and Moberg Pharma go up and down completely randomly.

Pair Corralation between Orexo AB and Moberg Pharma

Assuming the 90 days trading horizon Orexo AB is expected to generate 0.62 times more return on investment than Moberg Pharma. However, Orexo AB is 1.61 times less risky than Moberg Pharma. It trades about 0.09 of its potential returns per unit of risk. Moberg Pharma AB is currently generating about 0.0 per unit of risk. If you would invest  1,498  in Orexo AB on September 14, 2024 and sell it today you would earn a total of  322.00  from holding Orexo AB or generate 21.5% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Orexo AB  vs.  Moberg Pharma AB

 Performance 
       Timeline  
Orexo AB 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Orexo AB are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Orexo AB unveiled solid returns over the last few months and may actually be approaching a breakup point.
Moberg Pharma AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Moberg Pharma AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental drivers, Moberg Pharma is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Orexo AB and Moberg Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Orexo AB and Moberg Pharma

The main advantage of trading using opposite Orexo AB and Moberg Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Orexo AB position performs unexpectedly, Moberg Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Moberg Pharma will offset losses from the drop in Moberg Pharma's long position.
The idea behind Orexo AB and Moberg Pharma AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Global Correlations
Find global opportunities by holding instruments from different markets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities